Practical Reproductive and Developmental Toxicology

Speaker Bios

Christopher J. Bowman, PhD, DABT

Dr. Chris Bowman has over 25 years of experience in reproductive and developmental toxicology. For the past 15 years, he has worked in the biopharmaceutical industry in Drug Safety Research and Development at Pfizer, based in Groton, CT. At Pfizer, his primary role is subject matter expert in developmental & reproductive toxicology but also serves as drug safety representative on project teams and study director. Prior to Pfizer, Dr. Bowman served as a DART study director at WIL Research Laboratories (currently Charles River Laboratories) in Ashland, OH, and before that he was a post-doctoral fellow researching antiandrogens at CIIT in Research Triangle Park, NC. He received his BS in interdisciplinary science and Ph.D. in pharmacology/toxicology from the University of Florida. Dr. Bowman is a Diplomate of the American Board of Toxicology and has over 60 peer-reviewed articles and book chapters. Since graduate school, Dr. Bowman has been and continues to be actively engaged in multistakeholder working groups and scientific committees, as well as currently serving as an Associate Editor of the Birth Defects Research journal and Industry Chair of the HESI DART Technical Committee. Dr. Bowman is a Past President of the Society of Toxicology Reproductive & Developmental Toxicology Specialty Section, was a participant on the International Council on Harmonization S5(R3) expert working group, and is a past member of the BioSafe Leadership Committee.

Justin M. Conley, PhD

Dr. Justin Conley is a Reproductive Systems Biologist in the Reproductive and Developmental Toxicology Branch at the USEPA in Research Triangle Park, NC. He received a PhD in Environmental Toxicology from North Carolina State University and then trained as a Postdoctoral Toxicologist at the EPA before becoming a Principal Investigator in 2019. Currently, his research focuses on the reproductive and development toxicity of in utero exposure to individual chemicals and mixtures, primarily PFAS and endocrine disrupting chemicals including pesticides and plasticizers. His work utilizes in vitro and in vivo approaches to elucidate mechanisms of toxicity, model dose response relationships, determine relative potency, and assess mixture-based responses. He is an active member of the Society of Toxicology and is currently the Senior Councilor of the Mixtures Specialty Section. He has authored/co-authored more than 30 peer-reviewed journal articles in the field of toxicology and been awarded multiple Scientific Achievement and Honor Awards for his research at the USEPA.

George Daston, PhD

George Daston is Victor Mills Society Research Fellow at the Procter & Gamble Company, the highest scientific rank achievable. He has published over 150 articles and book chapters and edited five books in toxicology and risk assessment. His most cited papers are on the topics of mechanistic approaches to characterize dose-response and risk from estrogenic chemicals, the role of toxicity-induced micronutrient deficiencies in developmental toxicity, and identifying that the triazines melamine and cyanuric acid were responsible for an epidemic of acute renal failure in dogs and cats in North America, and later in babies in China. His current research efforts are in the areas of cheminformatics, toxicogenomics and predictive and mechanistic toxicology, particularly in addressing how findings in these fields can improve risk assessment for chemicals and the development of non-animal alternatives. Dr. Daston has served as President of the Teratology Society, Treasurer and President of the Society of Toxicology, on the USEPA’s Science Advisory Board, Board of Scientific Counselors and Endocrine Disrupter Screening and Testing Advisory Committee, National Toxicology Program Board of Scientific Counselors, National Research Council’s Board of Environmental Studies and Toxicology, and National Children’s Study Advisory Committee. In his advisory role at EPA, he oversaw the chartering and first five years of EPA’s acclaimed Computational Toxicology Program. He was the founding editor of Birth Defects Research: Developmental and Reproductive Toxicology. With scientists at the Humane Society of the US, Dr. Daston founded the AltTox website, which is devoted to the exchange of scientific information leading to the development of non-animal replacements for toxicity assessments. Dr. Daston has been awarded the Josef Warkany Lectureship and the Distinguished Service Award by the Teratology Society, the George H. Scott Award by the Toxicology Forum, the Society of Toxicology’s Best Paper of the Year Award, and is an elected Fellow of AAAS. Dr. Daston is an adjunct Professor of Pediatrics at University of Cincinnati and Cincinnati Children’s Hospital Research Foundation and of Veterinary Physiology at Texas A&M University.

Jamie DeWitt, PhD, DABT

Dr. DeWitt is a Professor in the Department of Pharmacology & Toxicology of the Brody School of Medicine at East Carolina University. Her research program explores relationships between biological organisms and their responses after exposure to environmental contaminants with a specific focus on the immune system and its interactions with the nervous system during development and adulthood. Dr. DeWitt’s research program has a particular focus on emerging environmental contaminants, especially per- and polyfluoroalkyl substances (PFAS). She received doctorate degrees in Environmental Science and Neural Science from Indiana University-Bloomington and completed postdoctoral training in immunotoxicology at the US Environmental Protection Agency in partnership with the University of North Carolina at Chapel Hill. She is the author or co-author of 46 peer-reviewed articles, 27 reviews/commentaries, and 13 book chapters. She edited the first comprehensive book on PFAS toxicity, co-edited a book on immunotoxicity testing, and is an Associate Editor for Toxicology and Applied Pharmacology. She also serves on the editorial boards of the Journal of Immunotoxicology, Environmental Health Perspectives, NeuroToxicology, Reproductive and Developmental Toxicology, Journal of Toxicology and Environmental Health, and Chemosphere. She has been active in the Society of Toxicology since graduate school and is a member of the Membership Committee. She also has served as the postdoctoral representative, counselor, vice-president, and president of the Immunotoxicology Specialty Section and is a past president of the North Carolina Regional Chapter.

Hisham A. El-Masri, PhD

Hisham completed his PhD in 1994 from Colorado State University followed by two years as a postdoctoral fellow In the Laboratory of Computational Biology and Risk Analysis at NIEHS. His postdoctoral research efforts focused on the application of computational models to link pharmacokinetics and pharmacodynamics processes to develop quantitative dose-response relationships for susceptible populations. After his post-doc, Hisham worked in the Computational Toxicology and Methods Development (CompTox) Laboratory at ATSDR. Currently, Hisham is a research health scientist in the Center for Computational Toxicology and Exposure (CCTE) at the US EPA. He works on the development and application of computational models to identify hazardous exposure to environmental chemicals using high-throughput screening assays (HTS), specifically looking at life-stage factors. He has over 50 publications in peer-reviewed journals and book chapters.

Gerald B. Grunwald, PhD

Gerald B. Grunwald, PhD, Dean of the Jefferson College of Biomedical Sciences. A Jefferson faculty member since 1985, Dr. Grunwald assumed his current position in September 2010. In addition to serving as Dean of JCBS, he is currently tenured Professor in the Department of Pathology, Anatomy, and Cell Biology, in the Sidney Kimmel (formerly Jefferson) Medical College. Dr. Grunwald was born in Brooklyn, NY and attended public schools there and later in Port Washington, NY. He received his BA cum laude in Biology from Cornell University and his MS and PhD in Zoology from the University of Wisconsin. Prior to joining Jefferson, he was engaged in postdoctoral studies as a Senior Staff Fellow at the National Institutes of Health.

As Dean of the Jefferson College of Biomedical Sciences, Dr. Grunwald serves as the chief academic and administrative officer of the school, with responsibility for the planning and execution of its education and training mission. Dr. Grunwald has been active in research and training in the field of cell and developmental biology of the eye. His work has been published in over fifty peer-reviewed papers and invited book chapters, with research support provided primarily by the National Eye Institute of the NIH. His laboratory has served as a training venue for many graduate students and postdoctoral fellows. He has served on numerous research grant review panels for federal and private agencies, including as Chair of the Visual Sciences C study section of the NIH. Additional research recognition has included his election as Chair of the Gordon Conference on Cell Contact and Adhesion and appointment to a Burroughs Wellcome Visiting Professorship

Dr. Grunwald has a strong record as an academic leader and his commitment to education is well recognized by students and senior administrators alike. In his thirty years at Jefferson, he has been instrumental in the development and delivery of educational and training programs in both the Sidney Kimmel Medical College as well as the Jefferson College of Biomedical Sciences. He has served as director of MS and PhD graduate programs, as director of numerous graduate and medical college courses, and in development of policies for postdoctoral training. Recognition of his role in education has included the Lindback Foundation Award for Distinguished Teaching, Honorary Life Membership in the Jefferson College of Biomedical Sciences Alumni Association, the Dean’s Citation for Significant Contributions to the Advancement of Education at Jefferson Medical College, the Faculty Award for Neuroscience Education of the PhD Program in Neuroscience, the Distinguished Mentor Award of the Jefferson Postdoctoral Association and Office of Postdoctoral Affairs, the Teacher of the Year Award from the Freshman Class of Sidney Kimmel Medical College, and the SKMC Senior Class Portrait in 2014.

Dr. Grunwald has served on and chaired numerous committees within JCBS and SKMC, and is currently chair of the university’s Institutional Biosafety Committee and the Committee on Conflict of Interest and Commitment. He has also served as chair of the SKMC Committee on Research, and has held leadership positions on several committees dealing with accreditation and strategic planning efforts.

Alan M. Hoberman, PhD, DABT, ATS

Dr. Hoberman has been employed by Charles River Laboratories, Preclinical Services, Pennsylvania (formerly Argus Research Laboratories, Inc.) since 1981. Currently he is Executive Director, Global Developmental, Reproductive, and Juvenile Toxicology. He is a Diplomat of the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences, with over 85 publications and book chapters. He is the co-editor of “Pediatric Non-Clinical Drug Testing, Principles, Requirements, and Practices” published in January 2012.

Dr. Hoberman has been a member of the American College of Toxicology since 1979 and is currently the Past President. He has been a member of the Society for Birth Defects Research and Prevention (BDRP) since 1978. He is a past president of BDRP, Reproductive and Developmental Toxicity Specialty Section of the Society of Toxicology, the Middle Atlantic Reproductive and Teratology Association and the Arkansas Biotechnology Organization.

Terry Hrubec, PhD, DVM

Terry Hrubec earned her DVM and PhD from the veterinary college at Virginia Tech. She is currently a professor at the Edward Via College of Osteopathic Medicine where she teaches Anatomy and Embryology. She has mentored over 80 research students in both Medical and Veterinary colleges. Her research focuses on how environmental exposures affect reproduction and development, particularly through neuroendocrin and immune regulation. She has taught human embryology to medical students for 20 years and is pleased to discuss the normal development of the respiratory system for the American College of Toxicology DART course.

E. Sid Hunter III, PhD

Dr. Sid Hunter is Chief of the Systems Biology Branch, Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory (NHEERL) in the Office of Research and Development in the US Environmental Protection Agency (US EPA). Dr. Hunter earned a BS in Chemistry and MS in Toxicology. His PhD is in Anatomy and Embryology from the University of North Carolina–Chapel Hill, and he joined the Reproductive Toxicology Division of NHEERL at US EPA in 1993 as a Research Toxicologist. He presently holds an appointment of Faculty Affiliate at University of North Carolina–Chapel Hill in the Toxicology Curriculum.

Dr. Hunter’s research interests and activities have focused on understanding the mechanisms responsible for chemically-induced developmental toxicity. He used the whole embryo culture technique to study neural tube closure and early craniofacial development and evaluated the morphological, metabolic, transcriptional, and proteomic effects of chemicals. The Hunter lab used an adherent mouse embryonic stem cell culture model to evaluate the effects of ToxCast compounds and selected chemical libraries on stem cell differentiation and proliferation. These data are being used to determine signaling pathways important in embryogenesis and stem cells. As part of the US EPA’s virtual tissues research program, the Hunter lab is working to establish organotypic culture models of early human heart and neurovascular development to evaluate chemical effects and contribute to the creation of computer and predictive models of chemical effects on human development.

Brian Johnson, PhD

Dr. Johnson received a BS in Biology from Michigan Technological University in 2004, worked in industry and after returning to academia in 2007, earned a PhD in Molecular and Environmental Toxicology in Chris Bradfield’s lab studying drug metabolism and vascular development in mouse models in 2013. He’s now a K99 fellow and assistant scientist in the Microtechnology Medicine Biology (MMB) lab at the University of Wisconsin-Madison where he creates devices and assays to model intercelluar signaling in development for 21st century toxicology. He’s also spun-off a company from his research, won prizes in the Transform Tox Testing challenge put forth by the EPA/NIH as well as several other State and Federal grants including a K99.

Aileen Keating, PhD, MS

Dr. Keating is an Associate Professor at Iowa State University, where she conducts research on the impact of chemical exposures on female reproductive health. She received her doctorate in Biochemistry from the National University of Ireland, Galway in 2003 and was a postdoctoral fellow at the University of Alberta from 2004–2006, and the University of Arizona from 2006–2010. She is author or co-author of 79 peer-reviewed articles and nine book chapters. She serves on the board of directors for the Society for the Study of Reproduction. She has been a member of the Society of Toxicology (SOT) since 2006 and has served the SOT in the following capacities: Counselor for the Central States (CS) chapter of SOT (CS-SOT; 2011–2012), CS-SOT President (2012–2014), Early Career Counselor for the Reproductive and Developmental Toxicology Specialty Section (RDTSS) (2014–2016), and from 2016-2021 as vice-president elect to past-president of the RDTSS. In 2019, she was awarded the Stephen B. Harris Mid-Career Scientist Award from the RDTSS. She serves as a reviewer for the National Institutes of Health and the Canadian Institutes of Health Research. Her research investigates: 1) the mechanisms by which ovotoxicants compromise ovarian function; 2) the ovarian protective response to ovotoxic xenobiotic exposures; and 3) the ovarian biotransformation processes that contribute to ovotoxicity. The ultimate aim of these studies is to minimize female reproductive dysfunction that is a consequence of ovotoxic chemical exposures.

Susan B. Laffan, PhD

Susan Laffan, PhD is currently a Head of the Nonclinical Global Investigative Safety group at GlaxoSmithKline, she has over 18 years of pharmaceutical industry experience. Susan is the nonclinical chair of the Medicine’s for Children Network providing advice to drug development teams on their pediatric development plans. Dr. Laffan represented PhRMA on the ICH S11 Working Group. She is an expert in reproductive and developmental toxicology and has been directly involved on the drug development teams supporting the safety assessment of compounds from discovery through post marketing. Susan earned a PhD in toxicology from the University of North Carolina and Chapel Hill, conducting her dissertation at the USEPA, Research Triangle Park, NC. In addition to being a BDRP member, she is a member of the Society of Toxicology and the ILSI/HESI DART Technical Committee.

Jessica LaRocca, PhD

Jessica LaRocca is the Predictive Human Health Sciences team leader at Corteva Agriscience. Her research areas of interest include endocrine disruption, developmental toxicology, regulatory toxicology, and in vitro alternatives. Her current role focuses on leveraging “New Approach Methodologies” (NAMs) for predictive and mechanistic toxicology studies to support the development of novel plant protection products. Prior to this role, she worked as a toxicology subject matter expert and regulatory sciences team leader for Corteva Agriscience since 2014. She has led the strategic implementation in Corteva of zebrafish models to predict developmental toxicity and endocrine disruption, and cellular and molecular models to predict general toxicity and cancer. She is currently the SOT Molecular and Systems Biology Specialty Section VP-elect. Prior to joining Corteva, she completed her postdoctoral fellowship at the Harvard University Center for the Environment, where her research focused on environmental epigenetic epidemiology. She received her doctorate from Brown University in Pathobiology, with a concentration in Environmental Pathology.

Robert Lipinski, PhD

Dr. Robert Lipinski is an Associate Professor in the Department of Comparative Biosciences in the School of Veterinary Medicine at the University of Wisconsin. He received his BS in Biology and PhD in Molecular and Environmental Toxicology from the University of Wisconsin, followed by postdoctoral training in embryology with Dr. Kathleen Sulik at the University of North Carolina at Chapel Hill. Dr. Lipinski’s research program investigates the interaction of genetic and environmental factors in etiologically complex craniofacial birth defects, including cleft lip and palate, and holoprosencephaly. These studies focus in part on the Sonic Hedgehog signaling pathway, which is required for morphogenesis of the forebrain and face and sensitive to both genetic and environmental disruption. In addition to research, Dr. Lipinski directs a Developmental Anatomy course for first year DVM students and teaches developmental toxicology in the Molecular and Environmental Toxicology graduate curriculum at the University of Wisconsin.

Joshua F. Robinson, PhD

Dr. Robinson is an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the University of California, San Francisco (UCSF), where he leads a research program aimed at studying the effects of environmental chemical exposures during pregnancy and their mechanistic links with developmental disease. His background and training include a MS and PhD in Toxicology from the University of Washington and six combined years of postdoctoral training at the National Institute of Public Health and the Environment in the Netherlands and UCSF. He has extensive experience using in vitro, in vivo, in silico and omic-approaches to investigate the relationship between chemical exposures and developmental/placental toxicity. He has published over 49 peer-reviewed manuscripts and book chapters. He has received several awards due to his early research accomplishments including the K99/R00 Pathway to Independence Award and the Society for Birth Defects Research and Prevention (BDRP) F. Clarke Fraser Early Investigator Award. He is a member of the Editorial Board of Reproductive Toxicology. He currently serves as Councilor of BDRP and is also an active member of the Society of Toxicology.

John M. Rogers, PhD

Dr. John Rogers is the Director of the Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC. Prior to that he served as Chief of the Developmental Biology Branch, and he has been with US EPA for 32 years. Dr. Rogers is also a graduate faculty affiliate in the Curriculum in Toxicology, University of North Carolina–Chapel Hill, and Adjunct Professor at North Carolina State University College of Veterinary Medicine. He received his PhD in Biology from the University of Miami (FL), and was a National Eye Institute postdoctoral fellow at the University of California–Davis. Dr. Rogers’s research addresses mechanisms of abnormal development, including maternally-mediated developmental toxicity, maternal nutrition, and the developmental origins of health and disease. Dr. Rogers is a past president of the Teratology Society, a member of the Society of Toxicology (SOT), past president of the Reproductive and Developmental Toxicity Specialty Section of SOT, and a member of the International Society for Developmental Origins of Health and Disease (DOHaD). Dr. Rogers has published over 125 peer-reviewed papers, invited reviews and book chapters, and has edited two books. Dr. Rogers has received 13 US EPA Scientific and Technical Achievement Awards for his published works and three Bronze Medals for service to US EPA.

Donald G. Stump, PhD, DABT

Dr. Stump earned a BS in toxicology from the Philadelphia College of Pharmacy and Science (1985). In addition, Dr. Stump received a PhD in biochemistry from Vanderbilt University (1990) and postdoctoral training at the National Institutes of Health. He is employed at Charles River Laboratories–Ashland and his current title is Senior Director, Toxicology. In this role, he oversees the General Toxicology, Developmental and Reproductive Toxicology, and Pharmacology and Discovery Services departments. Dr. Stump has published numerous research articles, book chapters, and abstracts. He has also made several presentations at regional and national meetings including meetings hosted by the American College of Toxicology, Society of Toxicology, Teratology Society, Korean Society of Nonclinical Study, and the North American Congress of Clinical Toxicology. He is currently on the journal editorial board for both Birth Defects Research and Congenital Anomalies. In addition, he is currently serving on the NTP Board of Scientific Counselors. He is a diplomate of the American Board of Toxicology (1999) and a member of the Teratology Society, the European Teratology Society, the Japanese Teratology Society, the Society of Toxicology, the American College of Toxicology, and the Japanese Society of Toxicology.

Cecilia Tan, MS, MBA, PhD

Dr. Cecilia Tan is a Senior Scientist in the Office of Pesticide Programs Health Effects Division. Her research experience includes environmental engineering, occupational health and safety, human health assessment, and computational modeling, particularly pharmacokinetic modeling. In her current role at the EPA, she evaluates the quality and integrity of kinetic data and models, uses kinetic information to interpret in vivo and in vitro dose-response data, and provides scientific guidance to toxicologists and regulators. She co-chaired the development of the Organization for Economic Cooperation and Development (OECD) guidance document on physiologically based kinetic modeling. She has also served as the co-chair of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) in vitro to in vivo Extrapolation Workgroup.

Kary Thompson, PhD

Dr. Kary Thompson is currently Global Head of Study Toxicology at Janssen Pharmaceuticals where she has oversight of general, developmental, reproductive, and juvenile toxicology. She received her PhD in Physiology from the University of Arizona and completed a postdoctoral fellowship at the US EPA. Dr. Thompson has 20 years of experience in the pharmaceutical industry, previously working at Bristol-Myers Squibb Company for as a DART study director/monitor, Director of DART, and a safety assessment project team representative. Dr. Thompson is a Past President of the Reproductive and Developmental Toxicology Specialty Section (RDTSS) of SOT, Past President of Middle Atlantic Reproduction and Teratology Association (MARTA), Past Industry Chair of the HESI DART working group, Adjunct Faculty at Rutgers, and served as a developmental toxicology expert for National Academy of Science committees. She was recognized with the Stephen B. Harris Mid-Career Scientist Award by RDTSS in 2020.

Charles V. Vorhees, PhD

Charles V. Vorhees, PhD, is Professor of Pediatric Neurology, Cincinnati Children’s Research Foundation & University of Cincinnati College of Medicine. He received his BA with Honors in Psychology/Biology from the University of Cincinnati and MA and PhD in Neurobiology from Vanderbilt University. He has worked on the developmental effects of anticonvulsants, amphetamines (methamphetamine, MDMA, fenfluramine, and “Foxy”), manganese, stress, PCBs, and pyrethroids and on genetic LOF models of Pde1b, Npas3, Lphn3, Slc6A8, Slc3010A, Lphn3, Cyp1a2, and others. He has served on advisory panels for NRC, US FDA, US EPA, and ILSI. He was a regular member of an NIH study section for four years and has served as an ad hoc member on 32 other study sections. He has also reviewed grants for US FDA, Oak Ridge National Laboratory, US EPA, Wellcome Trust, UK MRC, New Zealand, Israel, Ireland, Canada, March of Dimes, Azerbaijan, American Chemistry Council, NSF, and the VA. He has reviewed manuscripts for 78 different journals. He is a faculty member of graduate programs in Neuroscience and in Molecular & Developmental Biology. He has been advisor to 15 doctoral and 17 postdoctoral fellows. He teaches in graduate courses on neuroscience, teratology, pharmacology, and developmental biology. He has published >300 papers and book chapters and been funded by NIH, NSF, US FDA, and DOD and other sources for >35 years. He is PI of an NIH T32 training grant in its 40th year. He was Director of Graduate Studies for the Neuroscience Graduate Program for 4 years, and held positions in the Molecular and Developmental Biology Graduate Program for 15 years, including last six as Program Director. He was Editor-in-Chief of Neurotoxicology & Teratology for nine years and Section Editor for 12 years. He is a founding member of the Developmental Neurotoxicology Society and has served as President twice, and served as Treasurer, Finance, Constitution, and Nominations committees, on Council and is the current Secretary. He is a member of the Teratology Society (since 1977), Society for Neuroscience, Society of Toxicology, International Behavioral Neuroscience Society, and AAAS.

Ida M. Washington, DVM, PhD, DACLAM

Dr. Washington earned her DVM in 1987 and became a member of the BDRP (then Teratology) Society in 1988 while she was a graduate student in Dr. Tom Sadler’s lab at UNC-Chapel Hill. After her Ph.D., she spent 14 years as a professor at NC State College of Veterinary Medicine, teaching anatomy and embryology to veterinary students and performing basic research on diabetes-induced heart defects. She moved into laboratory animal medicine in 2004, became a Diplomate in the American College of Laboratory Animal Medicine in 2010, and has served as an Attending Veterinarian and Director of laboratory animal programs at several academic institutions. Dr. Washington is currently the University Veterinarian and Director of the Office of Animal Care Management at the University of Vermont in Burlington VT. Throughout her career, Dr. Washington has maintained an interest in teratology and reproductive toxicology and has stayed active in the BDRP Society, serving on numerous committees and councils and regularly attending annual meetings

Tacey White, PhD

Dr. Tacey White is a Senior Consultant at Aclairo Pharmaceutical Development Group where she is the Lead for Developmental, Reproductive, and Juvenile Toxicology. She received her PhD in Toxicology from the University of Rochester and completed postdoctoral fellowships at the University of Rochester and Fox Chase Cancer Center. Dr. White has been a consultant since 2012, advising pharmaceutical and biotech companies on nonclinical safety assessment strategies, placing and monitoring studies, developing human risk assessments for toxicology issues, addressing regulatory questions, and contributing to regulatory documents. Dr. White has deep regulatory and investigative expertise in developmental and reproductive toxicity (DART), and juvenile toxicity, and assists clients with FDA Pregnancy Labeling (PLLR), and pediatric development plans for EMA (PIP) and FDA (PSP). Dr. White spent 14 years in the pharmaceutical industry where she was a DART study director, the director of an investigative DART laboratory, and a safety assessment project team representative. She was also Global Director of Small Animal DART at Covance Labs. Dr. White is a Past President of the US Teratology Society (Vice President: 2014–2015, President: 2015–2016), and actively participates in the ILSI/HESI DART working group, including co-organization of the FDA Pregnancy and Lactation Label Rule workshop (2015), and participation in the Neonatal Pediatric Therapeutics workgroup.